Tag: Phase
Roflumilast Cream Effective for AD in Phase 3 Studies Medscape Source link
– Statistically significant improvements in IGA (Investigator Global Assessment) and EASI ( Eczema Area and Severity Index) scores – Fast itch reduction by day 4 and sustained itch reduction – Body Surface Area (BSA) reduction of at least 50 percent – Significant improvement in Skin Infection Rating Scale (SIRS) ANNAPOLIS, Md. , July 10, 2023 […]
Reistone Biopharma Co. Ltd. said both doses of the JAK1 inhibitor ivarmacitinib, tested against moderate to severe atopic dermatitis (AD) in a multinational phase III trial, met the study’s co-primary endpoints, delivering significant improvements on a common measure of disease severity vs. placebo. It’s the first National Class A new drug for AD that is […]